Header Logo

COREEN DOMINGO

Concepts (52)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
6
2020
208
0.620
 Why?
Vaccines
4
2014
381
0.500
 Why?
Doxazosin
2
2020
28
0.300
 Why?
Substance-Related Disorders
1
2013
491
0.290
 Why?
Dopamine beta-Hydroxylase
2
2018
29
0.240
 Why?
Adrenergic alpha-1 Receptor Antagonists
2
2020
19
0.180
 Why?
Polymorphism, Genetic
3
2020
803
0.160
 Why?
Receptors, Adrenergic, alpha-1
1
2020
17
0.160
 Why?
Buprenorphine
1
2019
102
0.140
 Why?
Cocaine
3
2014
214
0.130
 Why?
Schizophrenic Psychology
1
2016
85
0.120
 Why?
Smoking Cessation
1
2016
191
0.110
 Why?
Amphetamine-Related Disorders
1
2014
38
0.100
 Why?
Drug Design
1
2014
161
0.100
 Why?
Cholera Toxin
1
2013
51
0.100
 Why?
Molecular Targeted Therapy
1
2014
402
0.090
 Why?
Immunotherapy
2
2014
748
0.090
 Why?
Stress Disorders, Post-Traumatic
1
2019
651
0.090
 Why?
Vaccination
2
2014
1017
0.090
 Why?
Smoking
1
2016
942
0.080
 Why?
Double-Blind Method
3
2020
1653
0.080
 Why?
Pharmacogenetics
2
2020
200
0.060
 Why?
Quality of Life
1
2016
2152
0.060
 Why?
Humans
10
2022
132105
0.060
 Why?
Pilot Projects
2
2020
1451
0.050
 Why?
Genotype
2
2020
2706
0.050
 Why?
Middle Aged
6
2020
28936
0.050
 Why?
Treatment Outcome
4
2019
13017
0.040
 Why?
Clinical Trials as Topic
2
2014
1158
0.040
 Why?
Receptors, Opioid, kappa
1
2019
23
0.040
 Why?
Comparative Effectiveness Research
1
2019
71
0.040
 Why?
Narcotic Antagonists
1
2019
110
0.040
 Why?
Norepinephrine
1
2018
166
0.030
 Why?
Male
6
2020
64918
0.030
 Why?
Combined Modality Therapy
1
2020
1296
0.030
 Why?
Female
6
2020
70680
0.030
 Why?
Adult
4
2020
31557
0.030
 Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2016
229
0.030
 Why?
Haptens
1
2014
7
0.030
 Why?
Analgesics, Opioid
1
2019
471
0.030
 Why?
Safety
1
2014
216
0.030
 Why?
Methamphetamine
1
2014
50
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2013
89
0.020
 Why?
Antibodies
1
2014
367
0.020
 Why?
Research Design
1
2014
743
0.020
 Why?
Global Health
1
2014
616
0.020
 Why?
Young Adult
2
2014
9940
0.020
 Why?
Randomized Controlled Trials as Topic
1
2013
1246
0.020
 Why?
Adolescent
2
2014
20532
0.010
 Why?
United States
1
2019
11627
0.010
 Why?
Animals
2
2014
34953
0.010
 Why?
Retrospective Studies
1
2019
17374
0.010
 Why?
DOMINGO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (52)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_